Wednesday, November 04, 2020 9:25:24 AM
Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger
Nicosia, Cyprus, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals,
Inc. OTC:(RAFA) is pleased to announce that the elite Chicago auditing firm LJ
Soldinger Associates (https://www.soldinger.com/) has been retained to provide
auditing services for the resulting Rafarma group of companies from the
Biocogency/Rafarma merger.
Ilya Spurov, Chairman of Rafarma, commented: “The reputation of LJ Soldinger
Associates gives us confidence that our transition will be smooth,
professional and efficient.”
https://www.bloomberg.com/press-releases/2020-11-04/auditing-firm-l-j-soldinger-associates-retained-for-rafarma-biocogency-merger
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM